X4 Pharmaceuticals to Report Fourth-Quarter and Full-Year
BOSTON, March 07, 2023 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and
Globe Newswire7-03-2023, 20:04
Scott Parnell Improves Customer Experience, Productivity and Delivery Sustainability with Descartes’ Electronic Proof of Delivery 18-06-2024, 17:45